Is Lutikizumab, an Anti–Interleukin-1<i>α</i>/<i>β</i> Dual Variable Domain Immunoglobulin, efficacious for Osteoarthritis? Results from a bayesian network meta-analysis

<div>The forest plots. The forest plots of pain relief and function improvement for network meta-analysis. (SMD: standardised mean difference; CI: confidence interval).</div>

BioMed Research International

fig2

Figure 2

Figure 2: Is Lutikizumab, an Anti–Interleukin-1<i>α</i>/<i>β</i> Dual Variable Domain Immunoglobulin, efficacious for Osteoarthritis? Results from a bayesian network meta-analysis 

Figure 2 | Is Lutikizumab, an Anti–Interleukin-1α/β Dual Variable Domain Immunoglobulin, efficacious for Osteoarthritis? Results from a bayesian network meta-analysis 